These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 7419719

  • 21. [Plasma 1.25 (OH)2D and PTH levels and urinary cyclic AMP response to exogenous PTH in PHP during childhood (author's transl)].
    Seino Y, Ishida M, Shimotsuji J, Ishii T, Matsuda S.
    Horumon To Rinsho; 1979 Aug; 27(8):879-84. PubMed ID: 226296
    [No Abstract] [Full Text] [Related]

  • 22. The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism.
    Mizunashi K, Furukawa Y, Abe K, Yoshinaga K.
    Calcif Tissue Int; 1993 Dec; 53(6):378-83. PubMed ID: 8293350
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. 1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism.
    Epstein S, Meunier PJ, Lambert PW, Stern PH, Bell NH.
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):241-7. PubMed ID: 6687971
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. 25-Hydroxyvitamin D3 loading test in primary hyperparathyroidism, hypoparathyroidism and pseudohypoparathyroidism.
    Miura R, Furukawa Y, Yumita S, Sohn HE, Mizunashi K, Yoshinaga K.
    Endocrinol Jpn; 1987 Feb; 34(1):97-104. PubMed ID: 3608916
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Heterogeneity of pseudohypoparathyroidism type I from the aspect of urinary excretion of calcium and serum levels of parathyroid hormone.
    Mizunashi K, Furukawa Y, Sohn HE, Miura R, Yumita S, Yoshinaga K.
    Calcif Tissue Int; 1990 Apr; 46(4):227-32. PubMed ID: 2108792
    [Abstract] [Full Text] [Related]

  • 33. Reduced serum levels of 1 alpha,25-dihydroxyvitamin D during long-term total parenteral nutrition.
    Klein GL, Horst RL, Norman AW, Ament ME, Slatopolsky E, Coburn JW.
    Ann Intern Med; 1981 May; 94(5):638-43. PubMed ID: 6786151
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Evidence for alteration of the vitamin D-endocrine system in obese subjects.
    Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S.
    J Clin Invest; 1985 Jul; 76(1):370-3. PubMed ID: 2991340
    [Abstract] [Full Text] [Related]

  • 36. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR, Baylink DJ, Jones PG, Haussler MR.
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.